[Corrigendum] Repositioning of duloxetine to target pancreatic stellate cells

Sagara,Akiko; Nakata,Kohei; Matsumoto,Sokichi; Guan,Weiyu; Shinkawa,Tomohiko; Iwamoto,Chika; Ikenaga,Naoki; Ohuchida,Kenoki; Nakamura,Masafumi

doi:10.3892/ol.2026.15789

October-2026 Volume 32 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

October-2026 Volume 32 Issue 4

Full Size Image

Correction Open Access

[Corrigendum] Repositioning of duloxetine to target pancreatic stellate cells

Authors:
- Akiko Sagara
- Kohei Nakata
- Sokichi Matsumoto
- Weiyu Guan
- Tomohiko Shinkawa
- Chika Iwamoto
- Naoki Ikenaga
- Kenoki Ohuchida
- Masafumi Nakamura
View Affiliations / Copyright

Affiliations: Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812‑8582, Japan

Copyright: © Sagara et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 434
|
Published online on: July 30, 2026

https://doi.org/10.3892/ol.2026.15789
Expand metrics +

Article

Oncol Lett 22: [Related article:] 744, 2021; DOI: 10.3892/ol.2021.13005

Subsequently to the publication of the above article, an interested reader drew to the authors’ attention that, concerning the cellular migration assay data shown in Fig. 4A on p. 7, the ‘+Duloxetine’ and ‘+PSC-SN’ data panels showed an overlapping section, such that these were apparently derived from the same original source where the results of differently performed experiments were intended to have been portrayed.

Figure 4.

Duloxetine suppresses tumor-stromal interactions by attenuating secretomes from PSCs. (A) Representative photomicrographs of invading and migrating SUIT-2 cells in monoculture and indirect coculture with drugs or supernatants following hematoxylin and eosin staining. Magnification, ×100. Scale bar, 100 µm. (B) Graphs show the number of invading and migrating SUIT-2 cells. (C) Western blotting of extracellular matrix proteins in PSC supernatant and drug-treated PSC supernatant. (D) Relative mRNA expression of growth factors and cytokines associated with tumor-stromal interactions in PSCs treated with duloxetine. The expression levels of each gene were normalized to GAPDH. (E) Western blotting of PP2A and related proteins in whole cell lysates of PSCs treated with duloxetine at various concentrations (1, 5 and 10 µM). Values indicate densitometric ratios normalized to α-tubulin. *P<0.05, **P<0.01, ****P<0.0001 vs. control group. PSCs, pancreatic stellate cells; PSC-SN, PSC supernatant; Dulo-SN, supernatant from PSCs treated with duloxetine; PP2A, protein phosphatase 2A; COL1A1, α-1 type-1 collagen; POSTN, periostin; CTGF, connective tissue growth factor; HGF, hepatocyte growth factor; IL-1β, interleukin-1β; IL-6, interleukin-6; p, phosphorylated.

After re-examining their original data, the authors have realized that the data correctly shown for the ‘+Duloxetine’ data panel had inadvertently been duplicated as the ‘+PSC-SN’ data panel. As a result, the images originally shown for the PSC-SN migration group were incorrectly taken from the duloxetine group. After reviewing the laboratory notebooks and primary data files, the authors have identified the correct data panel for the ‘+PSC-SN’ experiment, and the revised and corrected version of Fig. 4 is shown on the next page. The authors are grateful to the Editor of Oncology Letters for allowing them this opportunity to publish a Corrigendum, and all the authors agree with its publication. Furthermore, the authors apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Repositioning of duloxetine to target pancreatic stellate cells

This article is mentioned in:

Article

Figure 4.

Related Articles